Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose safety, tolerability, and pharmacokinetics study of CN128 in healthy volunteers
TCTR20161110001Phase 1Not yet recruiting
- Sponsor
- Professor Yongping Yu
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Tiralos, sponsored by Professor Yongping Yu. Primary endpoints: Safety and tolerability of single-dose CN128 and Pharmacokinetics of CN128. Planned start Feb 2017; status: not yet recruiting.
02
Drugs
Tiralos
Beyond the preview
Go deeper on TCTR20161110001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20161110001.